Louis Chen
Stock Analyst at Scotiabank
(0.10)
# 4,473
Out of 5,182 analysts
11
Total ratings
18.18%
Success rate
-44.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Sector Outperform | $140 → $177 | $141.54 | +25.05% | 2 | Feb 11, 2026 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $4.37 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $60.10 | -8.49% | 1 | Feb 24, 2022 |
Gilead Sciences
Feb 11, 2026
Maintains: Sector Outperform
Price Target: $140 → $177
Current: $141.54
Upside: +25.05%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.37
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $60.10
Upside: -8.49%